Name | diethyl 2,6-dimethyl-4-(2,3,4,5,6-pentafluorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
---|---|
Synonyms |
HMS3262D09
2,6-dimethyl-4-pentafluorophenyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester Diethyl-4-(2,3,4,5,6-pentafluoro)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Nemadipine-A |
Description | Nemadipine-A is a specific inhibitor of the EGL-19 L-type Ca2+ channel[1]. Nemadipine-A, a cell-permeable L-type calcium channel inhibitor, sensitizes TRAIL-resistant cancer cells to this ligand[2]. |
---|---|
Related Catalog | |
In Vitro | Nemadipine-A is a specific and highly effective inhibitor of EGL-19. Nemadipine-A (µM) is sufficient to abolish the enhanced level of paralysis observed in egl-19(ad695); crIs4 mutants[1]. Nemadipine-A strongly potentiates TRAIL-induced apoptosis in TRAIL-resistant lung cancer cells via the down-regulation of the anti-apoptotic protein survivin[2]. Nemadipine-A sensitizes H1299 lung cancer cells towards TRAIL-induced cytotoxicity[2]. Combination of Nemadipine-A (20 μM) with TRAIL (20 ng/mL) induces caspase-mediated apoptotic cell death[2]. Cell Viability Assay[2] Cell Line: H1299 lung adenocarcinoma cells Concentration: 0, 5, 10, 20, and 30 μM Incubation Time: 8 hours Result: H1299 cells were resistant to the apoptotic effects of TRAIL, but the co-administration of Nemadipine-A and TRAIL in these cells resulted in notably increased cytotoxicity in a dose-dependent manner. Western Blot Analysis[2] Cell Line: H1299 cells Concentration: 20 μM Incubation Time: 8 hours Result: Co-treated with TRAIL and Nemadipine-A (T/N; 20 ng/mL and 20 μM respectively) induced cell death in H1299 cells. |
References |
Molecular Formula | C19H18F5NO4 |
---|---|
Molecular Weight | 419.34300 |
Exact Mass | 419.11600 |
PSA | 64.63000 |
LogP | 4.07190 |
~92% 54280-71-6 |
Literature: Sharma, Mukul; Agarwal, Nisha; Rawat, Diwan S. Journal of Heterocyclic Chemistry, 2008 , vol. 45, # 3 p. 737 - 739 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |